Source: GlobeNewswire, BioSpace
Area: News
The US Food and Drug Administration (FDA) has granted "orphan drug" status for verteporfin (Visudyne) for the potential treatment of chronic or recurrent central serous chorioretinopathy (CSC).
Uncategorized